Bazelet science team, assembled from experts in the fields of chemistry, biology, medicine and pharmaceutical, leads the company in product and technology developments. Implementing their rich know-how from different disciplines, the science team direct our R&D processes to create advanced solutions for needs raised by patients and industry. The team leads the innovation and research at Bazelet in the fields of extractions, compounds analysis, products and formulations, developing medical cannabis products to suit different medical needs. This is done by incorporating the acquired scientific knowledge to direct medical cannabis usage.
Bazelet science team, assembled from experts in the fields of chemistry, biology, medicine and pharmaceutical, leads the company in product and technology developments. Implementing their rich know-how from different disciplines, the science team direct our R&D processes to create advanced solutions for needs raised by patients and industry. The team leads the innovation and research at Bazelet in the fields of extractions, compounds analysis, products and formulations, developing medical cannabis products to suit different medical needs. This is done by incorporating the acquired scientific knowledge to direct medical cannabis usage.
Dr. Alon Eisenberg
Medical Director
Graduated Debrecen university Faculty of Medicine; Clinical Herbalist & Naturopath; diverse interdisciplinary clinical experience in conventional, herbal & integrative medicine in the EU & Israel; managed professional medical content for a variety of medical companies and organizations; MD thesis focused on pharmacotherapy novel approaches of major depression disorder.
Dr. Noa Raz
Senior Scientific Adviser
Dr. Noa Raz holds a PhD in neuroscience. She conducts various neurological-related studies trying to explore the neuroanatomical substrate of different diseases, incorporating multi-disciplinary approach. In Bazelet, Noa leads the research of medical Cannabis for treating various neurological, psychiatric and pain related conditions, incorporating the acquired scientific knowledge to direct medical cannabis usage.
Dr. Dana Berneman-Zeitouni
Research and Development manager
Obtained her Ph.D degree in the field of human genetics and biochemistry from the Department of Human Genetics, Sackler Faculty of Medicine, Tel-Aviv University.
Served as research leader in fields of diabetes and parkinson disease, Neurosurgery department and The Stem cell and regenerative medicine center, Tel-Hashomer Hospital
And she is also a licensed herbalist.
Iso Heller
Pharmaceutical division manager
Retail business expert and adviser of Medical, Natural Products and Cosmetics.
B.Pharm. – Hebrew University of Jerusalem M.Sc Molecular Biology and Human Genetics – Tel -Aviv University.Experienced Manager and Head Pharmacist of number of stores in leading Drugstore chain in Israel. Specializations in management, training, customer care, sales and various aspects of Pharmaceutical business.
Consultants
Dr. Michael Zviely
Dr. Michael Zviely holds a Ph.D. in chemistry from the Hebrew University as well as a visiting professor at Jiangnan University in China. His field of specialty includes aroma chemicals – flavor and fragrance ingredients, botanical extracts, cooling agents and UV sunscreen ingredients. Dr. Zviely has over 30 years of experience in chemical industries, including positions as project manager, VP and in R&D. He had published more than 20 patents, over 60 articles and chapters in monographs on flavors and fragrances. Currently, Dr. Zviely serves as a senior consultant on technology and strategy of specialty fragrance and flavor ingredients to companies in Israel, Europe, India and China.
Prof. Sharoni Shafir
is at the Department of Entomology in the Robert H. Smith Faculty of Agriculture, Food and Environment of the Hebrew University of Jerusalem. He is the Director of the B. Triwaks Bee Research Center. He obtained his Ph.D. from Stanford University in 1995. Prof. Shafir’s scientific interests are in the areas of: bee biology, nutritional ecology, perception, learning, and decision making, and the use of bees for pollination. He has authored over 60 papers in peer-reviewed journal.
Harry J. Gwinnell
is a senior counsel at the Greenblum & Bernstein, P.L.C. Previously, Mr. Gwinnell had served as a vice-president and chief Intellectual Property counsel at Cargill incorporated, and as a patent examiner in the U.S. patent and trademark office. He has been chosen by the intellectual asset management magazine to be one of the world’s leading IP strategists and had received the president’s distinguished service award from the intellectual property owners association. Mr. Gwinnell has his Juris Doctorate from the Columbus school of law and a bachelor of science in chemistry from Villanova University; he is a recognized speaker and author in the area of Intellectual Capital Management.